Spok announces strategic alternatives review; adopts limited-duration shareholder rights plan

Spok Holdings, Inc

Board initiated strategic review after receiving multiple private expressions of interest to acquire the company.
Acacia Research/Starboard Value accumulated >5% of SPOK stock; Board invited them to participate equally.
Adopted limited-duration poison pill effective immediately; triggers at 10% (20% passive) ownership, expires Aug 31, 2022.
Rights plan includes shareholder-friendly feature: allows special meeting to exempt a qualifying offer.
No assurance that review will result in a sale or transaction.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.